Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerulosclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05267262
What this trial is testing

Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis

Who this might be right for
Alport SyndromeFocal Segmental Glomerulosclerosis
River 3 Renal Corp. 43
Not applicableStudy completedNCT04369183
What this trial is testing

Rituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change Disease
Istanbul University 25
Not applicableUnknownNCT00956059
What this trial is testing

Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental Glomerulosclerosis
Xi'an Jiaotong University 40
Not applicableLooking for participantsNCT01209000
What this trial is testing

Nephrotic Syndrome Study Network

Who this might be right for
Minimal Change Disease (MCD)Membranous NephropathyGlomerulosclerosis, Focal Segmental
University of Michigan 1,200
Not applicableLooking for participantsNCT01094327
What this trial is testing

Proteinuria in Pre and Post Transplant

Who this might be right for
Proteinuria
University of Miami 100
Testing effectiveness (Phase 2)Study completedNCT00040508
What this trial is testing

Sirolimus for Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Glomerulosclerosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Testing effectiveness (Phase 2)Study completedNCT05213624
What this trial is testing

Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis

Who this might be right for
Kidney Disease, Chronic
Boehringer Ingelheim 67
Large-scale testing (Phase 3)Looking for participantsNCT07220083
What this trial is testing

Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Focal Segmental Glomerulosclerosis
Boehringer Ingelheim 286
Large-scale testing (Phase 3)Study completedNCT01268033
What this trial is testing

Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During Childhood

Who this might be right for
Childhood Idiopathic Nephrotic Syndrome
University Hospital, Limoges 26
Testing effectiveness (Phase 2)Study completedNCT02000440
What this trial is testing

A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Glomerulosclerosis, Focal Segmental
GlaxoSmithKline 17
Early research (Phase 1)Looking for participantsNCT05942625
What this trial is testing

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects

Who this might be right for
IgA NephropathyFocal Segmental Glomerulosclerosis
Hansoh BioMedical R&D Company 84
Early research (Phase 1)Study completedNCT00353535
What this trial is testing

Total Lymphoid Irradiation (TLI) to Prevent Focal Segmental Glomerulosclerosis (FSGS)Recurrence in the Renal Graft

Who this might be right for
Glomerulosclerosis, Focal
University of Sao Paulo 10
Testing effectiveness (Phase 2)Study completedNCT03649152
What this trial is testing

Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan

Who this might be right for
Focal Segmental Glomerulosclerosis
Dimerix Bioscience Pty Ltd 8
Not applicableLooking for participantsNCT04571658
What this trial is testing

NEPTUNE Match Study

Who this might be right for
Nephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more
University of Michigan 375
Testing effectiveness (Phase 2)Study completedNCT00007475
What this trial is testing

Permeability Factor in Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental Glomerulosclerosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 15
Large-scale testing (Phase 3)Study completedNCT00135811
What this trial is testing

Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)

Who this might be right for
Glomerulosclerosis, Focal
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 192
Very early researchStudy completedNCT03763643
What this trial is testing

PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant

Who this might be right for
Focal Segmental Glomerulosclerosis
University of Minnesota 21
Post-approval studies (Phase 4)Ended earlyNCT01129557
What this trial is testing

Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease

Who this might be right for
Proteinuric Kidney DiseaseDiabetic NephropathyHypertensive Nephrosclerosis+4 more
Columbia University 46
Not applicableLooking for participantsNCT07516964
What this trial is testing

SLIT ABS: Study on Patients With Autoimmune Podocytopathy

Who this might be right for
Nephrotic Syndrome With Edema (Diagnosis)Minimal Change Nephrotic SyndromeFocal Segmental Glomerulosclerosis (FSGS)+1 more
Meyer Children's Hospital IRCCS 50
Testing effectiveness (Phase 2)Looking for participantsNCT06090227
What this trial is testing

AMPK-activation by Metformin in FSGS: AMP-FSGS

Who this might be right for
Focal Segmental Glomerulosclerosis
Yale University 30
Next Page